# Midway Pharmaceuticals Inc — Form D

Midway Pharmaceuticals Inc of Spring House, PA, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-27. The offering totals $300K, of which $300K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2017-04-27
- Form: D
- Accession: 0001369356-17-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $300K
- Amount sold: $300K
- Minimum investment: $10K
- Investors: 5
- Date of first sale: 2017-04-12
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-285591

## Issuer

- Name: Midway Pharmaceuticals Inc
- CIK: 0001369356
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2 Pump House Dr, Spring House, PA, 19477
- Phone: 215-628-0938

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Harry Arader | Director | Spring House, PA |
| Rifat Pamukcu | Director | Memphis, TN |
| Rifat Pamukcu | Executive Officer | Memphis, TN |

## More

- [CIK 1369356 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1369356&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001369356-17-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.